Related to Merck & Co. and Simcere Form JV to Expand Access to Drugs in China

• U.S. Stem Cell Companies Find Partners and Revenues Beyond the Water’s Edge
  Firms find it easier to navigate regulatory requirements in Asia as well as Europe.
  
• For Some Emerging Companies, the Road to Growth Connects the U.S. and China
  While American firms are tapping China’s size and regulatory path, Chinese biotechs are going west for money and expertise.
  
• Germany Anchors Translational Medicine Efforts with New Spending Plan and Centers
  Country hopes framework will augment alliances among its institutes as well as assuage industry drug pricing concerns.
  
• Studies Suggest that When It Comes to Drug Development Success, Size Matters
  Higher percentage of large molecules compared to small molecules makes it to market.
  
• Laying Sleep Disorders to Rest
  Innovative thinking is leading to new drugs that inhibit wakefulness rather than enhancing sleepiness.
  
• A SPA for PMTs
  Researchers propose a SPA strategy that can be successfully implemented to identify novel and specific inhibitors of PMTs.
  
• New Luciferins
  Researchers describe a rapid method to synthesize D-luciferin along with a novel set of electronically modified analogues.
  
• Blood Flow as Diagnostic Marker
  Jamming, or vaso-occlusion, could be used to distinguish sickle cell disease patients with poor outcomes from those with good outcomes.
  
• Obesity Drug Developers Post Steady Gains
  High clinical trial costs and slower FDA approvals are among the hurdles to obesity drug approval.
  
• Russia Establishes Clinical Trial Hub
  Cost and speed play big roles in the country’s increased presence in the market.
  
• 10 Best U.S. Regions to Secure a Biotech Job
  GEN shows you where careers are made.
  
• Binding MoA by DPI
  Researchers investigate the application of dual-polarization interferometry (DPI) as a method for the real-time characterization of low molecular weight ligands.
  
• DuBiotech: The Silicon Valley of Biotechnology
  The Dubai Biotechnology & Research Park is open for business and aiming to catch the eye of biotech companies.
  
• 25 Diabetes Drugs in the Pipeline Right Now
  Meet the new weapons in the war against the chronic metabolic disease.
  
• No Passage to India
  Private investment dearth clouds the future of the subcontinent’s fast-growing biopharma industry.
  
• Stockholm-Uppsala Region Ups the Ante
  The region bets big in the quest for international renown.
  
• On the Menu: Supersized Soda Wars
  The NYC ruling halting the ban on large-sized sugary beverages is unlikely to stop future court fights over anti-obesity laws.
  
• Poland Invests in Biotech Infrastructure
  Will it be enough for the industry to succeed?
  
• Seeking New Tools Against Alzheimer’s
  Numerous failures, many in late stages, litter the road to a safe, effective drug.
  
• What Will Succeed Lipitor as the Next Blockbuster Cholesterol-Lowering Drug?
  CETP inhibitors are vying to take over from statins, but one major failure hovers ominously.